Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | GRM8 | O00222 | 1/20 | 0.65 |
| ▸ | GRM6 | O15303 | 1/20 | 0.65 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.65 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.65 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.65 |
| ▸ | GRM5 | P41594 | 1/20 | 0.65 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.65 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.65 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.65 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.65 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.65 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.65 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.65 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.65 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.65 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.65 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.65 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1330943 | 1.00 | GSR (0.65) | GSRCYP1A2GRM8GRM6GRIN2D | |
| SCHEMBL3867126 | 1.00 | GSR (0.65) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Bromide SCHEMBL29951435 | 0.98 | GSR (0.62) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Ammonia Solution, Strong SCHEMBL25334885 | 0.98 | GSR (0.62) | GSRCYP1A2GRM8GRM6GRIN2D | |
| SCHEMBL26747924 | 0.86 | GSR (0.56) | GSRCYP1A2GRM8GRM6GRIN2D | |
| SCHEMBL10279976 | 0.86 | GSR (0.56) | GSRCYP1A2GRM8GRM6GRIN2D | |
| SCHEMBL27855469 | 0.85 | GRM8 (0.65) | GSRCYP1A2GRM8GRM6GRIN2D | |
| SCHEMBL12516455 | 0.84 | GSR (0.59) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Glutamic Acid SCHEMBL184513 | 0.83 | GRM8 (0.86) | GSRCYP1A2GRM8GRM6GRIN2D | |
| D-Glutamate SCHEMBL184512 | 0.83 | GRM8 (0.86) | GSRCYP1A2GRM8GRM6GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010771-A | 6-Diazonium-5-oxo-norleucine derivative, preparation method and application | 西北工业大学深圳研究院 | 2026-05-12 | — | — | CN | claimed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | claimed |
| CN-112689758-B | Device and method for checking the effect of a drug on microorganisms | 上海宜晟生物科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119584992-A | Antibody-drug conjugates comprising antibodies against human TROP2 and uses thereof | 瑞嘉化学生物科学股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | claimed |
| EP-4295866-A2 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2023-12-27 | — | — | EP | claimed |
| CN-114805138-B | Prodrugs of 6-diazo-5-oxo-L-norleucine, methods of making and uses thereof | 中国科学院长春应用化学研究所 | 2023-10-10 | — | — | CN | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| CN-116531346-A | Nanometer medicine for cisplatin-resistant tumor glutamine interference therapy and preparation method and application thereof | 滨州医学院 | 2023-08-04 | — | — | CN | claimed |
| CN-116510024-A | Composition, preparation method and application thereof | 上海复东生物医药有限责任公司 | 2023-08-01 | — | — | CN | claimed |
| CN-116283402-A | Fertilizer for relieving cotton boll period high temperature heat injury and preparation method and application thereof | 台沃科技集团股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| US-20210101941-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2021-04-08 | — | — | US | claimed |
| EP-3638284-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2020-04-22 | — | — | EP | claimed |
| CN-110891592-A | Cyclic peptides for protection against respiratory syncytial virus | 维罗米蒂克斯股份公司 | 2020-03-17 | — | — | CN | claimed |
| WO-2018229156-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2018-12-20 | — | — | WO | claimed |
| EP-2856170-B1 | METHODS FOR DIAGNOSING CHRONIC VALVULAR DISEASE | NESTEC SA (CH) | 2018-07-25 | — | — | EP | claimed |
| WO-2018112363-A1 | METHODS OF TREATING CANCER USING PARABACTEROIDES | EVELO BIOSCIENCES, INC. (US) | 2018-06-21 | — | — | WO | claimed |
| EP-2036918-A1 | PEPTIDE DERIVATIVE | Vexon, Inc. (JP) | 2009-03-18 | — | — | EP | claimed |
| US-20080009448-A1 | Peptide Derivative | VEXON, INC. (50%) (JP) | 2008-01-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIP, LNPEP, CSTB | GSR 1013/4885CYP1A2 4737/4885GRM8 3493/4885 |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIP, QPCT, QPCTL | GSR 1793/4885CYP1A2 4833/4885GRM8 1335/4885 |
| US-20210101941-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | QPCT, QPCTL, VIP | GSR 1643/4885CYP1A2 4771/4885GRM8 1035/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | GSR 864/4885CYP1A2 4695/4885GRM8 157/4885 |
| US-20080009448-A1 | Peptide Derivative | ARGLU1, NGLY1, NPR3 | GSR 4547/4885CYP1A2 1409/4885GRM8 2265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.